Skip to main content
Clinical Trials/IRCT20200526047576N1
IRCT20200526047576N1RecruitingPhase 3

Comparative Study of the Hemostatic Effect of Transamin on percutaneous nephrolithotomy surgery

Bagheiat-allah University of Medical Sciences0 sites64 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
64

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Patients should be between 18 and 60 years old
  • Patients weigh between 60 kg and 99 kg

Exclusion Criteria

  • History of anticoagulant use
  • History of blood diseases or HB less than 11 or PLT less than 140000

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Similar Trials

effect of transamin in percutaneous... | Clinical Trial